Clinical Trials Browser

INDUSTRY × Colorectal Neoplasms × apatinib × Clear all

NCT04073615 2024-05-02

A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)

Phase 1 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT01531777 2015-04-03

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms